HMC Capital: ASX Trade Table
HMC Capital is up 14.6% after 13 days.
Life 360: ASX Trade Table
Life360 is up 11.8% after 13 days.
Lendlease: Recovery Play
Lendlease buy with a stop loss below $6.09.
S&P Biotech
Global X S&P Biotech offers growth at a reasonable price. At $38, we rate this a strong buy.
Global Health Leaders
VanEck Vectors Global Health Leaders is likely to form a higher low with increased buying support at $9.70
International Small Companies
Vanguard MSCI International Small Companies Index has been added to our portfolio.
S&P500 & Market Direction
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
XJO & Market Direction
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Watch Last Night’s Webinar
In case you missed it, you can watch last night’s webinar here.
S&P500: Q3 Earnings
S&P 500 Q3 earnings increased for the first time since last year, with average EPS up 4% year over year. If energy is excluded, the result is more impressive at +10% growth.
S&P 500 EPS forecasts for the full year are $225, (largely the same as 2022), and in 2024 EPS growth is forecast to increase 5% to $237.
At 4500 points the S&P500 is trading at 20x forward EPS.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.